Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition.
NCT05324475 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2025-05-31
Summary
Aging is associated with an increased inflammation named "inflammageing" and with an altered immune response. Different mechanisms have been proposed to explain the phenomenon of inflammageing and increased oxidative stress: deficiencies in essential amino acids, and some micronutrients have an important impact and may induce immune cell dysregulation. Mitochondrial dysfunction may explain the complex relationship between malnutrition sarcopenia, immune dysfunction and aging.
Therefore, a personalized nutritional strategy aiming to improve mitochondrial function, decrease oxidative stress, down-regulate inflammation and restore immunity appears to be a logical approach in order to treat malnutrition and its biological and clinical consequences.
MIMOSA will investigate the role of nutritional supplements in rescuing altered mitochondrial function and redox state imbalance.
Conditions
- Malnutrition
- Sarcopenia
Interventions
- DIETARY_SUPPLEMENT
-
BCAA
daily administration of oral nutritional supplements (ONS) 1) providing whole proteins together with dietary advice according with the ESPEN nutrition guidelines. All the patients will receive the standard commercially available product used at CHUV (Resource protein ®, nestle) and nutritional counselling (SC) and 4 gram per day of BCAAs mixture. Ratio between the BCAAs will be Leucine/Isoleucine/Valine=2:1:1
- DIETARY_SUPPLEMENT
-
Micronutriments
daily administration of oral nutritional supplements (ONS) 1) providing whole proteins together with dietary advice according with the ESPEN nutrition guidelines. All the patients will receive the standard commercially available product used at CHUV (Resource protein ®, nestle ) and nutritional counselling (SC) and Vitamin A 1200 mg RE, Vitamin D3 2000 IU, Thiamine B1 100 mg, Cobalamin B12 10 mcg, Ascorbic acid C 200 mg, Iron 30 mg, Selenium 100 mcg, Zinc 20 mg, Omega-3 PUFA 1 g
- DIETARY_SUPPLEMENT
-
standard treatment + placebo
daily administration of oral nutritional supplements (ONS) 1) providing whole proteins together with dietary advice according with the ESPEN nutrition guidelines. All the patients will receive the standard commercially available product used at CHUV (Resource protein ®, nestle ) and nutritional counselling (SC) and maltodextrin 4 g as placebo
Sponsors & Collaborators
-
Patrizia D'Amelio
lead OTHER
Principal Investigators
-
Patrizia D'amelio · Service de gériatrie et réadaptation gériatrique-CHUV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2027-12-30
- Completion
- 2028-03-30
Countries
- Switzerland
Study Locations
More Related Trials
-
The Effect of AGE on the Immune System
NCT01959646 ·Status: COMPLETED ·Phase: NA
-
Effects of L-ARGinine and Liposomal Vitamin C Supplementation On Physical Performance
NCT06865261 ·Status: RECRUITING ·Phase: NA
-
2021 PMT iAge® Intervention Trial by Edifice Health
NCT04983017 ·Status: TERMINATED ·Phase: NA
-
Oral Nutritional Supplements in Treatment of Elderly Mild-to-Moderate COVID-19
NCT05629975 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dietary Supplementation on Dynamic Stability
NCT02806765 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Urolithin A (Mitopure) on Mitochondrial Quality in Muscle of Frail Older Adults
NCT06556706 ·Status: COMPLETED ·Phase: NA
-
Micronutrient Status Involved in Immunity in Elderly Patients With COVID-19
NCT04877509 ·Status: COMPLETED
-
Immune Function in Elderly Patients With Mild to Moderate COVID-19 on Hemodialysis
NCT05366205 ·Status: UNKNOWN ·Phase: NA
-
C15:0 Supplementation in Young Adults at Risk for Metabolic Syndrome
NCT04947176 ·Status: UNKNOWN ·Phase: NA
-
Impact of Orally Administered BPM31510 on Mitochondrial Energetics in Older Adults With Sarcopenia
NCT04999488 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital
NCT04947488 ·Status: UNKNOWN ·Phase: NA
-
Nutritional Intervention and Respiratory Infections in Older Subjects
NCT01971112 ·Status: UNKNOWN ·Phase: NA
-
Clinical Proof-of-concept Study on Rapid Immune Modulating Effects
NCT05364710 ·Status: UNKNOWN ·Phase: NA
-
Effect of Branched Chain Amino Acids on Muscle
NCT00170144 ·Status: COMPLETED ·Phase: NA
-
A Randomized Double Blind, Placebo Controlled Clinical Study Evaluating the Efficacy and Safety of Magnesium Supplementation on Relaxation in Adults
NCT07029607 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants
NCT05242718 ·Status: COMPLETED ·Phase: NA
-
Phytochemicals on "Metabolic Aging" in Older Overweight Adults
NCT04919876 ·Status: UNKNOWN ·Phase: NA
-
Fisetin Supplementation for Healthy Aging
NCT07195318 ·Status: RECRUITING ·Phase: NA
-
Carnitine Supplementation and Skeletal Muscle Function
NCT02692235 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study
NCT00821067 ·Status: COMPLETED ·Phase: NA
-
The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging
NCT06208527 ·Status: RECRUITING ·Phase: PHASE2
-
Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes
NCT02721537 ·Status: COMPLETED ·Phase: NA
-
Assessment of Physical Performance After Oral Supplementation of Magnesium in a Sample of Old Women in Good Health
NCT01971424 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
NCT04809974 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolomic Impacts of Branched-chain Amino Acid Supplementation During Endurance Exercise
NCT04969536 ·Status: COMPLETED ·Phase: NA